Patents by Inventor B. Longenecker

B. Longenecker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
    Publication number: 20070014844
    Abstract: The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1-based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation.
    Type: Application
    Filed: June 27, 2006
    Publication date: January 18, 2007
    Inventor: B. Longenecker
  • Synthetic glyco-lipo-peptides as vaccines
    Publication number: 20060069238
    Abstract: A glycolipopeptide comprising at least one disease-associated epitope, and characterized by at least one lipidated interior amino acid or by the presence of a MUC1 epitope, may be used in a vaccine, preferably in conjunction with a liposome.
    Type: Application
    Filed: April 9, 2003
    Publication date: March 30, 2006
    Applicant: Biomira, Inc.
    Inventors: R. Koganty, Zi-Hua Jiang, Damayanthi Yalamati, Sham Sandhi, Wladyslaw Budzynski, Mark Krantz, B. Longenecker
  • Lipopeptide adjuvants
    Publication number: 20020018806
    Abstract: Vaccine compositions containing a MUC-1-based adjuvant and an antigen are useful in treating and preventing disorders such as cancer and viral diseases. Exemplary compositions contain a 25-amino acid lipopeptide adjuvant and an antigen of interest in association with a liposome.
    Type: Application
    Filed: March 23, 2001
    Publication date: February 14, 2002
    Inventors: Babita Agrawal, Michael B. Longenecker, Joanne Parker